Evidence map›Paper›PMID 34703269›Full record

ArticleJournal of inflammation research2021

Capsaicin Protects Against Lipopolysaccharide-Induced Acute Lung Injury Through the HMGB1/NF-κB and PI3K/AKT/mTOR Pathways.

Hui Chen, Na Li, Xiang Zhan, Ting Zheng, Xinzhou Huang, Qianglin Chen, Zihao Song, Fei Yang, Hao Nie, Yanxiang Zhang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hui Chen *Department of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Na Li *Department of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Xiang Zhan *Department of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Ting ZhengDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Xinzhou HuangDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Qianglin ChenDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Zihao SongDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Fei YangDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Hao NieDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Yanxiang ZhangClinical Molecular Immunology Center, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Bing ZhengDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Quan GongDepartment of Immunology, School of Medicine, Yangtze University, Jingzhou, People's Republic of China.
Yangtze University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCapsaicin (8-methyl-N-geranyl-6-nonamide; CAP) is an alkaloid isolated from chili peppers, which has complex pharmacological properties, including beneficial effects against various diseases. The aim of this study was to investigate the role of CAP in lipopolysaccharide (LPS)-induced acute lung injury (ALI), and the possible underlying mechanisms. MATERIALS AND

methodsALI was induced by intranasal administration of LPS (0.5 mg/kg), and CAP (1 mg/kg) injected intraperitoneally 3 days before exposure to LPS. Then, the histopathological changes were evaluated by hematoxylin and eosin staining. Enzyme-linked immunosorbent assay and qPCR were used to detect pro-inflammatory cytokines in serum and lung tissue. The expressions of HMGB1/NF-κB, PI3K/AKT/mTOR signaling pathways and apoptosis-associated molecules were determined by Western blot and/or qPCR. In addition, the lung cell apoptosis was analyzed by TUNEL staining, and the expression and location of cleaved caspase-3 were detected by immunofluorescence analysis.

resultsCAP pretreatment significantly protected mice from LPS-induced ALI, with reduced lung wet/dry weight ratio, lung histological damage, myeloperoxidase (MPO) activity, malondialdehyde (MDA) content and pro-inflammatory cytokine levels, and significant increased superoxide dismutase (SOD) activity. In addition, CAP pretreatment significantly inhibited the high-mobility group protein B1 (HMGB1) expression, nuclear factor-kappa B (NF-κB) activation, and the PI3K/AKT/mTOR signaling pathway. Furthermore, mice pre-treated with CAP exhibited reduced apoptosis of lung tissues, with associated down-regulation of caspase-3, cleaved caspase-3, and BAX expression, and up-regulation of BCL-2.

conclusionOur data demonstrate that CAP can protect against LPS-induced ALI by inhibiting oxidative stress, inflammatory responses and apoptosis through down-regulation of the HMGB1/NF-κB and PI3K/AKT/mTOR pathways.

Indexed as

acute lung injuryapoptosiscapsaicinHMGB1/NF-κBinflammationPI3K/AKT/mTOR

Identifiers

PMID34703269
PMCPMC8524366
OpenAlexW3207019623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.